They’re all about us.
As you continue scrolling imagine this circle is a stem cell.
Stem cells are the body’s “master cells.” They are the building blocks of all organs, tissues, blood and the immune system. In many tissues they serve as an internal repair system, regenerating to replace lost or damaged cells for the life of a person.
Stem cells generate all the cells and structures of the human body from conception to end of life. There are three broad categories of stem cells and multiple tissue-specific stem cells types.
Stem cells generate all the cells and structures of the human body from conception to end of life. There are three broad categories of stem cells and multiple tissue-specific stem cells types.
NSCF supports only adult and iPS cell research and clinical trials.An iPS cell is an adult stem cell, most often a skin cell, that has been reprogrammed to revert back to a pluripotent state. iPS cells are already in use as tools for drug development and disease modeling. They are also in widespread research and clinical trial use to induce the production of missing cells that will halt or reverse catastrophic and currently incurable degenerative diseases. Because they are collected directly from the affected patient, there is no risk of transplant rejection, eliminating the serious complications of rejection common in transplants.
Embryonic stem cells are collected from in vitro fertilization clinics when donated to research with the consent of donor(s). In- vitro fertilization involves the joining of egg and sperm in a laboratory dish and freezing the resulting earliest stage embryo for future implantation. Embryos not needed for implantation may be donated to science, stored indefinitely or discarded. These cells are considered “pluripotent,” or capable of developing into all the cells and tissues of the human body.
Because embryonic stem cells are immature cells that multiply very rapidly, they often form tumors - a significant hurdle at present for human therapeutic use. Embryonic cells are most often used in research to model “diseases in a dish” to test or identify new drugs for the treatment of disease. The 2006 discovery that adult skin cells could be reprogrammed to behave like pluripotent stem cells largely leapfrogged the use of embryonic cells for clinical development.
Stem cells from bone marrow have been used since the 1950s to treat patients with certain types of blood cancer like leukemia or lymphoma. Donating stem cells can now be as easy as donating blood. Umbilical cord blood collected at birth also provides an abundant source of bone marrow stem cells and is often used to treat cancer and rare inherited disorders in children.
The ability to harness a renewable source of replacement cells and tissues holds promise for the treatment of multiple conditions including spinal cord injury, stroke, burns, heart disease, macular degeneration, osteoarthritis, autoimmune disease and neurodegenerative disease.
Stem cell therapies, gene therapies and new advances in technology have created a whole new field of “regenerative medicine” that focuses on the body’s own ability to repair or cure disease rather than treat it.
"We are not made of drugs, we are made of cells."
Stem cells are the body’s “master cells.” They are the building blocks of all organs, tissues, blood and the immune system. In many tissues they serve as an internal repair system, regenerating to replace lost or damaged cells for the life of a person.
Stem cells generate all the cells and structures of the human body from conception to end of life. There are three broad categories of stem cells and multiple tissue-specific stem cells types.
Stem cells from bone marrow have been used since the 1950s to treat patients with certain types of blood cancer like leukemia or lymphoma. Donating stem cells can now be as easy as donating blood. Umbilical cord blood collected at birth also provides an abundant source of bone marrow stem cells and is often used to treat cancer and rare inherited disorders in children.
The ability to harness a renewable source of replacement cells and tissues holds promise for the treatment of multiple conditions including spinal cord injury, stroke, burns, heart disease, macular degeneration, osteoarthritis, autoimmune disease and neurodegenerative disease.
Stem cell therapies, gene therapies and new advances in technology have created a whole new field of “regenerative medicine” that focuses on the body’s own ability to repair or cure disease rather than treat it.
All cells of the living human body are adult stem cells. Stem cells found in amniotic fluid, placenta and cord blood represent the earliest stage of adult stem cells and are routinely collected and “banked” for potential future use by the child. Many adult stem cell types are considered “multipotent,” or capable of developing into most cells and tissues of the body. Tissue-specific stem cells are capable of replacing only the tissues or organs in which they live.
*NSCF supports only adult and iPS cell research and clinical trials.An iPS cell is an adult stem cell, most often a skin cell, that has been reprogrammed to revert back to a pluripotent state. iPS cells are already in use as tools for drug development and disease modeling. They are also in widespread research and clinical trial use to induce the production of missing cells that will halt or reverse catastrophic and currently incurable degenerative diseases. Because they are collected directly from the affected patient, there is no risk of transplant rejection, eliminating the serious complications of rejection common in transplants.
Dr. Shinya Yamanaka and Sir John Gurden received the 2012 Nobel Prize in Medicine for their 2006 discovery of iPS cells.
Embryonic stem cells are collected from in vitro fertilization clinics when donated to research with the consent of donor(s). In vitro fertilization involves the joining of egg and sperm in a laboratory dish and freezing the resulting earliest stage embryo for future implantation. Embryos not needed for implantation may be donated to science, stored indefinitely or discarded. These cells are considered “pluripotent,” or capable of developing into all the cells and tissues of the human body.
Because embryonic stem cells are immature cells that multiply very rapidly, they often form tumors - a significant hurdle at present for human therapeutic use. Embryonic cells are most often used in research to model “diseases in a dish” to test or identify new drugs for the treatment of disease. The 2006 discovery that adult skin cells could be reprogrammed to behave like pluripotent stem cells largely leapfrogged the use of embryonic cells for clinical development.
“We are not made of drugs, we are made of cells.” Cade Hildreth, BioInformant.com
They can also be used to help a patient’s body recover from chemotherapy or radiation therapy.
Physicians and hospitals routinely offer new parents the opportunity to collect and store umbilical cord stem cells or future use by their newborn. Cord blood stem cells are capable of producing all blood cell types and are currently used in transplant medicine to regenerate healthy blood and immune systems. Cord blood banking preserves cells for the potential treatment of more than 80 known diseases and disorders. Banked cord blood cells are specific to the child, but may be donated to treat others.
Dentists and oral surgeons often offer patients the opportunity to bank the pulp of extracted teeth or lost baby teeth, a significant source of mesenchymal stem cells (MSC’s) with the potential to develop into multiple cell and tissue types if needed for future use.
Cord Blood Banking Dental Pulp Banking